Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Net Current Assets

    Back to Balance Sheet
INDO US BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Net Current Assets History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Current Assets (Including Current Investments) ₹56 Cr₹48 Cr₹35 Cr₹20 Cr₹15 Cr

What is the latest Net Current Assets ratio of INDO US BIOTECH ?

The latest Net Current Assets ratio of INDO US BIOTECH is ₹56 Cr based on Mar2024 Standalone results.
Year Net Current Assets
Mar2024₹56 Cr
Mar2023₹48 Cr
Mar2022₹35 Cr
Mar2021₹20 Cr
Mar2020₹15 Cr

How is Net Current Assets of INDO US BIOTECH Trending?

Years Net Current Assets % Change
Mar2024 ₹56 Cr
16.82
Mar2023 ₹48 Cr
36.64
Mar2022 ₹35 Cr
72.77
Mar2021 ₹20 Cr
32.97
Mar2020 ₹15 Cr -

Compare Net Current Assets of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹332.7 Cr 5.4% -12.8% -36.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,669.2 Cr -4.3% 0.1% 7.2% Stock Analytics
KAVERI SEED COMPANY ₹7,351.9 Cr 3.3% 29.3% 96.4% Stock Analytics
VENKYS (INDIA) ₹2,340.7 Cr -2.5% -1.7% -10.9% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,236.0 Cr -5.6% -14% -50.4% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹433.7 Cr -13.3% -20% NA Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

5.4%

-12.8%

-36.6%

SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses